Mark Identification

TAVANTA THERAPEUTICS

Serial Number

88916847

Filing Date

May 14, 2020

Trademark by

TAVANTA THERAPEUTICS INC.

Classification Information

Housemark for a full line of prescription pharmaceuticals for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals for treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex

Pharmaceuticals